Zydus Lifesciences Ltd
NSE :ZYDUSLIFE BSE :532321 Sector : PharmaceuticalsBuy, Sell or Hold ZYDUSLIFE? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
19 Nov 947.60 (0.31%) | 18 Nov 944.70 (-1.33%) | 14 Nov 957.40 (-0.66%) | 13 Nov 963.75 (1.47%) | 12 Nov 949.75 (-1.86%) | 11 Nov 967.75 (-0.27%) | 08 Nov 970.35 (-0.30%) | 07 Nov 973.25 (-2.20%) | 06 Nov 995.10 (0.67%) | 05 Nov 988.45 (-1.59%) | 04 Nov 1004.45 (0.04%) | 01 Nov 1004.00 (0.27%) | 31 Oct 1001.25 (1.61%) | 30 Oct 985.35 (-1.68%) | 29 Oct 1002.20 (-0.41%) | 28 Oct 1006.30 (1.58%) | 25 Oct 990.60 (-1.50%) | 24 Oct 1005.70 (0.47%) | 23 Oct 1001.00 (1.30%) | 22 Oct 988.20 (-1.74%) | 21 Oct 1005.70 (-1.64%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Very Bearish
Moving Averages
5 DMA
Bearish
952.72
10 DMA
Bearish
965.77
20 DMA
Bearish
982.32
50 DMA
Bearish
1033.96
100 DMA
Bearish
1102.47
200 DMA
Bearish
1038.96
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 19, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 968.39 | 961.77 | 951.37 | - | - |
R2 | 961.77 | 956.54 | 950.11 | 961.65 | - |
R1 | 954.69 | 953.3 | 948.86 | 954.45 | 958.23 |
P | 948.07 | 948.07 | 948.07 | 947.95 | 949.84 |
S1 | 940.99 | 942.84 | 946.34 | 940.75 | 944.53 |
S2 | 934.37 | 939.6 | 945.09 | 934.25 | - |
S3 | 927.29 | 934.37 | 943.83 | - | - |
Key Metrics
EPS
43.26
P/E
21.89
P/B
5.32
Dividend Yield
0.32%
Market Cap
95,351 Cr.
Face Value
1
Book Value
177.87
ROE
20.64%
EBITDA Growth
1,528.9 Cr.
Debt/Equity
0.05
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Zydus Lifesciences Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 4422.8 | 4564.7 | 5693.4 | 6270.7 | 5305.5 |
PROFIT | 801.7 | 767.8 | 1179.1 | 1419.9 | 910.9 |
EPS | 7.91 | 7.8 | 11.69 | 14.11 | 9.06 |
Zydus Lifesciences Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 2693.8 | 2478.1 | 3693.5 | 4266.8 | 2947.3 |
PROFIT | 805 | 450.4 | 1411.72 | 1700.8 | 789.8 |
EPS | 7.96 | 4.45 | 13.89 | 16.9 | 7.85 |
Profit & Loss (Figures in Rs. Crores)
Zydus Lifesciences Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 8804.1 | 9553.5 | 9643.7 | 12333.5 | 13476.4 | 14460.8 | 14605.3 | 18055.3 | 17185.9 | 20108.2 | |
PROFIT | 1157.11 | 1936.48 | 1488.67 | 1743.64 | 1793 | 1473.53 | 2369.75 | 4387.47 | 2387.89 | 3860.05 | |
EPS | 10.9 | 18.76 | 14.48 | 17.07 | 18.08 | 11.48 | 20.87 | 44.65 | 19.74 | 38.31 |
Zydus Lifesciences Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 5545.6 | 7156.7 | 3960.8 | 6204.7 | 6728.6 | 7240.6 | 8017.6 | 8062.5 | 9174.9 | 12035.2 | |
PROFIT | 1270.15 | 2038.39 | 662.54 | 1056.56 | 1411.26 | 1465.57 | 1633.15 | 1095.54 | 1621.47 | 3437.6 | |
EPS | 11.97 | 19.9 | 6.45 | 10.65 | 14.51 | 13.8 | 14.42 | 8.38 | 15.11 | 34.21 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 100.6 | 101.2 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 |
Reserves Total | 19,728.9 | 17,414.6 | 16,897.2 | 12,889.9 | 10,273.3 | 10,283.9 | 8,642.1 | 6,857.6 | 5,596.8 | 4,149.2 |
Total Shareholders Funds | 19,829.5 | 17,515.8 | 16,999.6 | 12,992.3 | 10,375.7 | 10,386.3 | 8,744.5 | 6,960 | 5,699.2 | 4,251.6 |
Minority Interest | 2,272.1 | 2,172.5 | 2,054.2 | 1,937.3 | 1,334.7 | 1,292.9 | 191 | 156.1 | 135.8 | 168.9 |
Secured Loans | 0 | 0 | 500 | 383.9 | 1,873.2 | 2,585.7 | 481.2 | 1,197 | 689.8 | 1,169.1 |
Unsecured Loans | 804.2 | 1,194.9 | 3,720.9 | 4,223.7 | 6,113.2 | 5,313.7 | 4,925.5 | 4,010.2 | 1,752.2 | 1,482.2 |
Total Debt | 804.2 | 1,194.9 | 4,220.9 | 4,607.6 | 7,986.4 | 7,899.4 | 5,406.7 | 5,207.2 | 2,442 | 2,651.3 |
Other Liabilities | 1,367.9 | 327.2 | 382.8 | 349.5 | 282.3 | 259.4 | 209.6 | 214 | 157.3 | 132.5 |
Total Liabilities | 24,273.7 | 21,210.4 | 23,657.5 | 19,886.7 | 19,979.1 | 19,838 | 14,551.8 | 12,537.3 | 8,434.3 | 7,204.3 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 19,919.8 | 18,343.8 | 17,650.9 | 17,345 | 16,781.5 | 15,702.3 | 9,349.1 | 8,102.9 | 5,767.3 | 5,138.5 |
Less: Accumulated Depreciation | 7,551.3 | 6,822.9 | 5,462.4 | 5,212.2 | 4,551 | 3,538.6 | 2,866.5 | 2,347.8 | 2,019.4 | 1,786.3 |
Net Block | 12,368.5 | 11,520.9 | 12,188.5 | 12,132.8 | 12,230.5 | 12,163.7 | 6,482.6 | 5,755.1 | 3,747.9 | 3,352.2 |
Capital Work in Progress | 2,423.3 | 1,200.7 | 725.9 | 783.2 | 741.5 | 837.2 | 1,527.2 | 1,543.3 | 950.8 | 797.9 |
Investments | 1,220.5 | 1,546.6 | 3,288 | 830.1 | 765 | 673.5 | 745.7 | 434.8 | 416.2 | 154.4 |
Inventories | 3,441.9 | 3,413.3 | 3,719.4 | 3,236.2 | 2,789 | 2,688 | 2,385.3 | 1,803.7 | 1,337.1 | 1,535.7 |
Sundry Debtors | 5,220.2 | 4,416.8 | 3,340.3 | 3,127.3 | 3,663.2 | 3,950.8 | 3,206.3 | 2,277.5 | 1,746.6 | 1,588.4 |
Cash and Bank Balance | 1,105.1 | 573.1 | 1,106.9 | 888.3 | 964.9 | 548.9 | 1,314.9 | 1,543.5 | 638.7 | 669.9 |
Loans and Advances | 1,400.1 | 985.7 | 1,575.4 | 1,265.3 | 1,085.5 | 1,080.5 | 1,048.4 | 348.5 | 358.9 | 311.5 |
Total Current Assets | 11,167.3 | 9,388.9 | 9,742 | 8,517.1 | 8,502.6 | 8,268.2 | 7,954.9 | 5,973.2 | 4,081.3 | 4,105.5 |
Current Liabilities | 3,793.8 | 3,829.4 | 3,576.7 | 3,460 | 3,225.3 | 3,203.4 | 3,079.2 | 2,498.1 | 1,834.1 | 1,398.8 |
Provisions | 766.8 | 522.2 | 407.4 | 418.3 | 272.3 | 189.4 | 152.2 | 68.9 | 81.3 | 382.5 |
Total Current Liabilities & Provisions | 4,560.6 | 4,351.6 | 3,984.1 | 3,878.3 | 3,497.6 | 3,392.8 | 3,231.4 | 2,567 | 1,915.4 | 1,784.2 |
Net Current Assets | 6,606.7 | 5,037.3 | 5,757.9 | 4,638.8 | 5,005 | 4,875.4 | 4,723.5 | 3,406.2 | 2,165.9 | 2,321.3 |
Deferred Tax Assets | 4,261.9 | 3,121.4 | 1,330.9 | 2,820.1 | 1,316.3 | 1,775.7 | 2,374.1 | 2,325.6 | 518.5 | 182.9 |
Deferred Tax Liability | 3,064.2 | 2,053.4 | 388.9 | 1,865.4 | 673.3 | 1,057.7 | 1,731.6 | 1,546.5 | 200.9 | 241.5 |
Net Deferred Tax | 1,197.7 | 1,068 | 942 | 954.7 | 643 | 718 | 642.5 | 779.1 | 317.6 | -58.6 |
Other Assets | 457 | 836.9 | 755.2 | 547.1 | 594.1 | 570.2 | 430.3 | 618.8 | 835.9 | 637.1 |
Total Assets | 24,273.7 | 21,210.4 | 23,657.5 | 19,886.7 | 19,979.1 | 19,838 | 14,551.8 | 12,537.3 | 8,434.3 | 7,204.3 |
Contingent Liabilities | 753.2 | 801.1 | 666.7 | 668 | 673.8 | 459.9 | 291.5 | 199 | 234.1 | 163.7 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 100.6 | 101.2 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 |
Reserves Total | 15,615.9 | 13,538.2 | 13,138.1 | 12,642.1 | 11,157.8 | 8,466.8 | 7,643.1 | 6,515.9 | 6,173.8 | 4,423 |
Total Shareholders Funds | 15,716.5 | 13,639.4 | 13,240.5 | 12,744.5 | 11,260.2 | 8,569.2 | 7,745.5 | 6,618.3 | 6,276.2 | 4,525.4 |
Secured Loans | 0 | 0 | 500 | 383.9 | 356.9 | 319.4 | 246.8 | 961.4 | 453.7 | 922.9 |
Unsecured Loans | 6,178.3 | 4,825.3 | 2,164.7 | 3,536 | 3,337.8 | 3,263.9 | 2,625.7 | 1,978.4 | 769.1 | 526.8 |
Total Debt | 6,178.3 | 4,825.3 | 2,664.7 | 3,919.9 | 3,694.7 | 3,583.3 | 2,872.5 | 2,939.8 | 1,222.8 | 1,449.7 |
Other Liabilities | 209.7 | 166.2 | 191.3 | 179.2 | 132.7 | 114.5 | 82.8 | 70.3 | 110.4 | 84.4 |
Total Liabilities | 22,104.5 | 18,630.9 | 16,096.5 | 16,843.6 | 15,087.6 | 12,267 | 10,700.8 | 9,628.4 | 7,609.4 | 6,059.5 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 8,677.4 | 7,999.8 | 7,675.6 | 7,009.1 | 6,564.2 | 6,152.3 | 4,515.7 | 3,896.3 | 3,720.5 | 3,118.9 |
Less : Accumulated Depreciation | 4,308 | 3,815.7 | 3,339.7 | 2,897.1 | 2,455.2 | 2,219.8 | 1,835.5 | 1,544.3 | 1,565.7 | 1,350.8 |
Net Block | 4,369.4 | 4,184.1 | 4,335.9 | 4,112 | 4,109 | 3,932.5 | 2,680.2 | 2,352 | 2,154.8 | 1,768.1 |
Capital Work in Progress | 633.9 | 739.3 | 384 | 570.5 | 552.6 | 674.9 | 659.2 | 678.4 | 296.8 | 366.9 |
Investments | 7,283 | 4,879.3 | 5,118 | 6,470.6 | 6,404.1 | 4,195.2 | 3,618.1 | 3,923.7 | 2,317.5 | 2,209.1 |
Inventories | 1,687.3 | 1,782.4 | 1,926.3 | 1,780 | 1,394.7 | 1,472.5 | 1,320.7 | 932.9 | 657.5 | 804.3 |
Sundry Debtors | 4,740.1 | 3,505.3 | 2,277.7 | 1,903.8 | 2,456.7 | 2,112.1 | 1,255.1 | 929 | 1,707.3 | 1,056.1 |
Cash and Bank Balance | 414.4 | 248.1 | 302.6 | 154 | 385.3 | 112.1 | 183.8 | 16.8 | 163.7 | 129.4 |
Loans and Advances | 1,069.5 | 1,420.8 | 2,110.3 | 2,193.9 | 556 | 560.6 | 797.8 | 260.7 | 293.9 | 249.2 |
Total Current Assets | 7,911.3 | 6,956.6 | 6,616.9 | 6,031.7 | 4,792.7 | 4,257.3 | 3,557.4 | 2,139.4 | 2,822.4 | 2,239 |
Current Liabilities | 1,669.2 | 1,539.3 | 1,384.5 | 1,401.7 | 1,195.1 | 1,157.9 | 1,217.3 | 1,283.7 | 1,074.3 | 814.8 |
Provisions | 252.8 | 199.1 | 105.9 | 111 | 70.5 | 89.6 | 52 | 29.8 | 54.9 | 339.5 |
Total Current Liabilities & Provisions | 1,922 | 1,738.4 | 1,490.4 | 1,512.7 | 1,265.6 | 1,247.5 | 1,269.3 | 1,313.5 | 1,129.2 | 1,154.3 |
Net Current Assets | 5,989.3 | 5,218.2 | 5,126.5 | 4,519 | 3,527.1 | 3,009.8 | 2,288.1 | 825.9 | 1,693.2 | 1,084.7 |
Deferred Tax Assets | 179.9 | 112 | 136.6 | 129.7 | 92.2 | 123.9 | 67 | 143.6 | 0 | 81.6 |
Deferred Tax Liability | 238.2 | 306.3 | 289.7 | 237 | 290.5 | 280.5 | 260.6 | 249.1 | 184.6 | 205.2 |
Net Deferred Tax | -58.3 | -194.3 | -153.1 | -107.3 | -198.3 | -156.6 | -193.6 | -105.5 | -184.6 | -123.6 |
Other Assets | 3,887.2 | 3,804.3 | 1,285.2 | 1,278.8 | 693.1 | 611.2 | 1,648.8 | 1,953.9 | 1,331.7 | 754.3 |
Total Assets | 22,104.5 | 18,630.9 | 16,096.5 | 16,843.6 | 15,087.6 | 12,267 | 10,700.8 | 9,628.4 | 7,609.4 | 6,059.5 |
Contingent Liabilities | 111 | 319.9 | 1,797.1 | 1,503.9 | 3,690.3 | 3,100.3 | 2,563.3 | 2,292 | 1,417.2 | 1,296 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 4,838.1 |
Depreciation | 764.1 |
Interest (Net) | -51.2 |
Dividend Received | 1.3 |
P/L on Sales of Assets | -13.4 |
Prov. and W/O (Net) | 61.1 |
P/L in Forex | -88.3 |
Others | -725 |
Total Adjustments (PBT and Ext... | 546.7 |
Operating Profit before Workin... | 5,384.8 |
Trade and 0ther Receivables | -747.2 |
Inventories | -2 |
Trade Payables | -44.8 |
Total Adjustments (OP before W... | -871.1 |
Cash Generated from/(used in) ... | 4,513.7 |
Direct Taxes Paid | -1,285.8 |
Total Adjustments(Cash Generat... | -1,285.8 |
Cash Flow before Extraordinary... | 3,227.9 |
Net Cash from Operating Activi... | 3,227.9 |
Purchased of Fixed Assets | -906.6 |
Sale of Fixed Assets | 23.7 |
Purchase of Investments | -106.7 |
Sale of Investments | 407.7 |
Interest Received | 127.4 |
Cancellation of Investment in ... | 55 |
Net Cash used in Investing Act... | -1,492.3 |
Proceed from 0ther Long Term B... | 1.4 |
Of the Long Tem Borrowings | -82.7 |
Of the Short Term Borrowings | -310.2 |
Dividend Paid | -621 |
Interest Paid | -72.9 |
Net Cash used in Financing Act... | -1,810.4 |
Net Profit before Tax and Extr... | 4,239.8 |
Depreciation | 504.4 |
Interest (Net) | 66.1 |
Dividend Received | 602.3 |
P/L on Sales of Assets | -13.6 |
Prov. and W/O (Net) | 49.2 |
P/L in Forex | -56.6 |
Others | -725 |
Total Adjustments (PBT and Ext... | -156 |
Operating Profit before Workin... | 4,083.8 |
Trade and 0ther Receivables | -1,255.1 |
Inventories | 95.1 |
Trade Payables | 90.9 |
Total Adjustments (OP before W... | -1,187 |
Cash Generated from/(used in) ... | 2,896.8 |
Direct Taxes Paid | -897.7 |
Total Adjustments(Cash Generat... | -897.7 |
Cash Flow before Extraordinary... | 1,999.1 |
Net Cash from Operating Activi... | 1,999.1 |
Purchased of Fixed Assets | -584.2 |
Sale of Fixed Assets | 18.8 |
Sale of Investments | 215.8 |
Interest Received | 295.1 |
Invest.In Subsidiaires | -2,670.7 |
Loans to Subsidiaires | -82.8 |
Cancellation of Investment in ... | 18.2 |
Net Cash used in Investing Act... | -1,830.6 |
Proceed from 0ther Long Term B... | 2,063.9 |
Of the Long Tem Borrowings | -360.8 |
Of the Short Term Borrowings | -352.3 |
Dividend Paid | -607.5 |
Interest Paid | -319.1 |
Net Cash used in Financing Act... | -300.8 |
Company Details
Registered Office |
|
Address | Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W |
City | Ahmedabad |
State | Gujarat |
Pin Code | 382481 |
Tel. No. | 91-079-26868100 |
Fax. No. | 91-079-26868337/26862365/26862366 |
dhavalsoni@zyduscadila.com; upen.shah@zyduscadila. | |
Internet | http://www.zyduscadila.com |
Registrars |
|
Address | Zydus Corporate Park S No 536 |
City | Ahmedabad |
State | Gujarat |
Pin Code | 382481 |
Tel. No. | 91-079-26868100 |
Fax. No. | 91-079-26868337/26862365/26862366 |
dhavalsoni@zyduscadila.com; upen.shah@zyduscadila. | |
Internet | http://www.zyduscadila.com |
Management |
|
Name | Designation |
Pankaj R Patel | Chairman (Non-Executive) |
Sharvil P Patel | Managing Director |
Mukesh M Patel | Non Executive Director |
Apurva S Diwanji | Independent Director |
Ganesh N Nayak | Whole-time Director |
Bhadresh K Shah | Independent Director |
Dhaval N Soni | Company Sec. & Compli. Officer |
Akhil A. Monappa | Independent Director |
Upasana Konidela. | Independent Director |
Shelina P. Parikh | Independent Director |